Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
ESC Heart Failure|January 10, 2022
The novel proteomic signature for cardiac allograft vasculopathyDongmei Wei, Sander Trenson, Jan M Van Keer, et al.
Research and Practice in Thrombosis and Haemostasis|April 13, 2022
Thromboprophylaxis in COVID-19: Weight and severity adjusted intensified dosingMatthias M Engelen, Christophe Vandenbriele, Valérie Spalart, et al.
Frontiers in Neurology|August 1, 2022
Subclinical Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Relation to Office and Ambulatory Blood Pressure MeasurementsJesus D Melgarejo, Gladys E Maestre, Jose Gutierrez, et al.
JACC. Basic to Translational Science|December 14, 2023
Protective Effect of Ticagrelor Against Infective Endocarditis Induced by Virulent <i>Staphylococcus aureus</i> in MiceCécile Oury, Severien Meyers, Nicolas Jacques, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical ExtentMarjolein P A Brekelmans, Harry R Büller, Michele F Mercuri, et al.
Thrombosis and Haemostasis|December 7, 2017
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE StudyAndria Medina, Gary Raskob, Walter Ageno, et al.
Thrombosis Research|December 18, 2017
Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trialThomas Vanassche, Peter Verhamme, Philip S Wells, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 30, 2021
Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trialThomas Vanassche, Peter Verhamme, Sonia S Anand, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 13, 2021
Normal-tension glaucomatous optic neuropathy is related to blood pressure variability in the Maracaibo Aging StudyJesus D Melgarejo, Gladys E Maestre, Luis J Mena, et al.
JAMA Cardiology|November 12, 2025
Major Bleeding With Apixaban vs Aspirin: A Subanalysis of the ARTESiA Randomized Clinical TrialDeborah M Siegal, Christian Sticherling, Jeff S Healey, et al.
Pageof 15